We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$44.4B
AUM Growth
+$1.2B
Cap. Flow
+$3.32B
Cap. Flow %
7.48%
Top 10 Hldgs %
17.65%
Holding
2,641
New
312
Increased
1,037
Reduced
994
Closed
281

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$555M
2
LLY icon
Eli Lilly
LLY
+$536M
3
META icon
Meta Platforms (Facebook)
META
+$433M
4
PGR icon
Progressive
PGR
+$330M
5
LRCX icon
Lam Research
LRCX
+$294M

Sector Composition

Rank Sector Weight
1 Technology 25.86%
2 Healthcare 15.38%
3 Financials 14.3%
4 Consumer Discretionary 11.43%
5 Industrials 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGTY
2101
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$224K ﹤0.01%
15,700
-67,900
-81% -$907K
VEON icon
2102
VEON
VEON
$3.5B
$222K ﹤0.01%
+5,100
New +$227K
VEL icon
2103
Velocity Financial
VEL
$696M
$222K ﹤0.01%
+11,859
New +$223K
CELC icon
2104
Celcuity
CELC
$4.06B
$221K ﹤0.01%
21,900
-29,300
-57% -$331K
NKTX icon
2105
Nkarta
NKTX
$152M
$221K ﹤0.01%
120,300
+16,800
+16% +$34.4K
IPGP icon
2106
IPG Photonics
IPGP
$3.4B
$221K ﹤0.01%
3,500
-19,900
-85% -$1.34M
UMH
2107
UMH Properties
UMH
$1.34B
$221K ﹤0.01%
+11,800
New +$215K
TBPH icon
2108
Theravance Biopharma
TBPH
$873M
$221K ﹤0.01%
+24,700
New +$230K
BBW icon
2109
Build-A-Bear
BBW
$445M
$219K ﹤0.01%
5,900
-600
-9% -$23.9K
MLNK
2110
DELISTED
MeridianLink
MLNK
$217K ﹤0.01%
11,700
+500
+4% +$9.66K
BNT
2111
Brookfield Wealth Solutions
BNT
$11.7B
$214K ﹤0.01%
6,150
-1,350
-18% -$51K
RCI icon
2112
Rogers Communications
RCI
$18.8B
$214K ﹤0.01%
+8,000
New +$226K
ARR
2113
Armour Residential REIT
ARR
$2.32B
$213K ﹤0.01%
12,481
-21,519
-63% -$401K
HNRG icon
2114
Hallador Energy
HNRG
$646M
$212K ﹤0.01%
17,300
-4,600
-21% -$51.7K
PLBC icon
2115
Plumas Bancorp
PLBC
$430M
$212K ﹤0.01%
4,900
-100
-2% -$4.48K
CRNX icon
2116
Crinetics Pharmaceuticals
CRNX
$8.88B
$211K ﹤0.01%
6,300
-1,800
-22% -$67.2K
RYZ
2117
Ryerson Holding Corp
RYZ
$1.49B
$211K ﹤0.01%
9,200
-7,300
-44% -$163K
LYEL icon
2118
Lyell Immunopharma
LYEL
$318M
$210K ﹤0.01%
19,560
+4,240
+28% +$51.9K
UTZ icon
2119
Utz Brands
UTZ
$1.24B
$210K ﹤0.01%
+14,900
New +$205K
OVLY icon
2120
Oak Valley Bancorp
OVLY
$284M
$210K ﹤0.01%
8,400
KYNB
2121
Kyntra Bio
KYNB
$27.4M
$210K ﹤0.01%
27,048
-8,088
-23% -$97K
METC icon
2122
Ramaco Resources Class A
METC
$629M
$209K ﹤0.01%
25,634
-307,469
-92% -$2.86M
PVBC
2123
DELISTED
Provident Bancorp
PVBC
$209K ﹤0.01%
18,200
+3,800
+26% +$44.4K
DC icon
2124
Dakota Gold
DC
$617M
$208K ﹤0.01%
78,600
+49,700
+172% +$136K
GAU
2125
Galiano Gold
GAU
$457M
$206K ﹤0.01%
166,400
+10,600
+7% +$13K

Similar funds

Two Sigma Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Two Sigma Advisers held 2,641 positions worth $44.4B, up 2.8% from $43.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Two Sigma Advisers deployed $3.32B of net new capital in Q1 2025, opening 312 new positions and adding to 1,037 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 553,800 shares worth $351M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Visa, an estimated $555M trimmed.

  • Two Sigma Advisers's largest Q1 2025 buy was Regeneron Pharmaceuticals: 553,800 shares worth $351M.
  • Two Sigma Advisers added most to Broadcom in Q1 2025, an estimated $519M increase.
  • Two Sigma Advisers's biggest Q1 2025 reduction was Visa, cutting an estimated $555M.
  • Two Sigma Advisers fully exited Abbott in Q1 2025, selling an estimated $158M.
  • Two Sigma Advisers's ten largest holdings make up 18% of its $44.4B portfolio in Q1 2025.
  • Two Sigma Advisers opened 312 new positions and closed 281 in Q1 2025.
  • Two Sigma Advisers's portfolio value rose 2.8% quarter-over-quarter to $44.4B.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.